In this study, the impact of cholesterol-lowering medications on breast cancer recurrence in women receiving adjuvant endocrine therapy was investigated.
Eating at least one avocado a day as part of a moderate-fat diet could help to lower "bad" cholesterol among the overweight and obese.
Findings suggest that elevated levels of cholesterol and triglycerides may be linked with greater risk of the prostate cancer recurrence, but normalization of blood fats may reduce risk.
High cholesterol may be associated with an increased risk for developing prostate cancer.
Researchers from the University of Illinois at Chicago have discovered how cholesterol activates a cellular signaling pathway linked to cancer development. Previous studies have associated high cholesterol with certain cancers. But in this study, the researchers focused on the signaling pathways used to direct cell function.
High cholesterol levels may increase a woman's risk of developing breast cancer, a large new British study reports.
People are often told to reduce their cholesterol to improve their health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease.
A by-product of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, according to researchers.
As cholesterol is metabolized, a potent stimulant of breast cancer is created—one that fuels estrogen receptor (ER)-positive breast cancers, according to new research.
Men with prostate cancer who used statin drugs prior to diagnosis had a decreased risk of prostate-cancer-specific mortality.
Cancer cells can be reprogrammed by DNA, siRNA, and miRNA, if only these nucleic acids could cross through the cell membrane. A new study shows that cholesterol rafts can deliver genetic payloads into cancer cells.
Lymphoma can be starved to death by depriving it of what appears to be a favorite food: HDL cholesterol. A new nanoparticle appears to the cancerous lymphoma cell like a preferred meal of natural HDL.
Persons with inflammatory breast cancer who were using statins at time of diagnosis had better progression-free survival than did nonusers.
Exemestane significantly reduced invasive breast cancer in postmenopausal women at elevated risk, but the aromatase inhibitor also lowered HDL cholesterol levels.
Researchers have demonstrated a link between high cholesterol and an increased risk of high-grade prostate cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention (2009;15:2807-2813).
Having low cholesterol levels may reduce a man's risk for high-grade prostate cancer, according to a study conduced by Johns Hopkins epidemiologists.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Encorafenib, Binimetinib Combination Receives FDA Approval for Mutation-Positive Melanoma
- Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|